UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Thiazolidinediones Increase Plasma-Adipose Tissue FFA Exchange Capacity and Enhance Insulin-Mediated Control of Systemic FFA Availability

Diabetes (New York, N.Y.), 2001-05, Vol.50 (5), p.1158-1165

2001

Volltextzugriff (PDF)

On the Role of Liver X Receptors in Lipid Accumulation in Adipocytes

Molecular endocrinology (Baltimore, Md.), 2003-02, Vol.17 (2), p.172-182

2003

Volltextzugriff (PDF)

Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats

American journal of physiology. Renal physiology, 1997-08, Vol.273 (2), p.246-F253

1997

Volltextzugriff (PDF)

456 Efficacy and safety of iptacopan in patients with primary IgA nephropathy: interim analysis results of the Phase 3 APPLAUSE-IgAN study

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

Safety and Efficacy of Iptacopan in Patients with IgA Nephropathy with Baseline eGFR 20 to <30 mL/min: Phase 3 APPLAUSE-IgAN Subcohort Results: FR-PO853

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats

American journal of physiology. Renal physiology, 1999-02, Vol.276 (2), p.F315-F322

1999

Volltextzugriff (PDF)

Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy

The New England journal of medicine, 2024-10

2024

Volltextzugriff (PDF)

WCN24-1506 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY

Kidney international reports, 2024-04, Vol.9 (4), p.S506-S506

2024

Volltextzugriff (PDF)

Tesaglitazar, a dual PPARα/γ agonist, ameliorates glucose and lipid intolerance in obese Zucker rats

American journal of physiology. Regulatory, integrative and comparative physiology, 2005-10, Vol.289 (4), p.R938-R946

2005

Volltextzugriff (PDF)

Depression of Myocardial Contractility Is Not a Causative Factor for Circulatory Deterioration in Two Experimental Models of Shock in Anesthetized Dogs

Annals of the New York Academy of Sciences, 1994-06, Vol.723 (1), p.345-348

1994

Volltextzugriff (PDF)

Tesaglitazar, a dual PPARalpha/gamma agonist, ameliorates glucose and lipid intolerance in obese Zucker rats

American journal of physiology. Regulatory, integrative and comparative physiology, 2005-10, Vol.58 (4), p.R938

2005

Volltextzugriff (PDF)

Salutary Effects of Dopexamine, a DA-1 and β-2 Agonist, on Free Radical-Induced Toxicity in Anesthetized Rats

Annals of the New York Academy of Sciences, 1994-06, Vol.723 (1), p.349-352

1994

Volltextzugriff (PDF)

Tesaglitazar, a dual PPARα/γ agonist, ameliorates glucose and lipid intolerance in obese Zucker rats

American journal of physiology. Regulatory, integrative and comparative physiology, 2005, Vol.58 (4), p.R938-R946

2005

Volltextzugriff (PDF)

Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats

American journal of physiology. Regulatory, integrative and comparative physiology, 2005-10, Vol.289 (4), p.R938-R946

2005

Volltextzugriff (PDF)

Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-meidated control of systemic FFA availability

Diabetes (New York, N.Y.), 2001-05, Vol.50 (5), p.1158

2001

Volltextzugriff (PDF)

Sustained Beneficial Metabolic Effects after Cessation of Thiazolidinedione Therapy in Insulin-Resistant Obese Zucker Rats

Diabetes (New York, N.Y.), 2000-05, Vol.49 (5), p.A284

2000

Volltextzugriff (PDF)

Thiazolidinediones Alter the Control of Systemic Free Fatty Acid Mobilization and Tissue Specific Utilization in Obese Zucker Rats

Diabetes (New York, N.Y.), 2000-05, Vol.49 (5), p.A290

2000

Volltextzugriff (PDF)

Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats

American journal of physiology. Renal physiology, 1999-02, Vol.45 (2), p.F315-F322

1999

Volltextzugriff (PDF)

Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats

American journal of physiology. Renal physiology, 1997-08, Vol.42 (2), p.F246-F253

1997

Volltextzugriff (PDF)

Effect of pharmacological interventions in the prevention of lipid peroxidation and respiratory depression induced by oxygen free radicals in anesthetized rats

Free radical biology & medicine, 1996, Vol.21 (6), p.791-799

1996

Volltextzugriff (PDF)

Comparative evaluation of the acute effects of oxygen free radicals on myocardial contractility in anesthetized dogs with those occurring in the early stages of splanchnic artery occlusion and hemorrhagic shock

Free radical biology & medicine, 1994-08, Vol.17 (2), p.171-179

1994

Volltextzugriff (PDF)

Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats

American journal of physiology. Renal physiology, 1999-02, Vol.276 (2), p.F315

1999

Volltextzugriff (PDF)

Efficacy and Mechanisms of Dopexamine in the Prevention of Ischemia-Reperfusion Induced Organ Damage: Role of Oxygen Free Radicals

Clinical and experimental hypertension (1993), 1997, Vol.19 (1-2), p.181-190

1997

Volltextzugriff (PDF)

Evaluation of the effects of felodipine, verapamil and hydralazine on the survival rate of rats subjected to lethal effects of oxygen free radicals

Naunyn-Schmiedeberg's archives of pharmacology, 1992-10, Vol.346 (4), p.457-461

1992

Volltextzugriff (PDF)

Studies on the eleterious effects of free radicals on myocardial contractility and hemodynamics in dogs: Protection by felodipine, a dihydropyridine calcium antagonist

Drug development research, 1992, Vol.27 (3), p.287-295

1992

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Animals
(9)
Rats
(8)
Biological And Medical Sciences
(5)
Male
(5)
Endocrinology & Metabolism
(4)
Lipid Metabolism
(4)
Physiology
(4)
Rats, Sprague-Dawley
(4)
Thiazolidinediones
(4)
Biochemistry & Molecular Biology
(3)
Diabetes
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Hypertension
(3)
Medical Sciences
(3)
Obesity
(3)
Oxygen Free Radicals
(3)
Physiological Aspects
(3)
Rats, Zucker
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Thiazolidinediones Increase Plasma-Adipose Tissue FFA Exchange Capacity and Enhance Insulin-Mediated Control of Systemic FFA Availability

On the Role of Liver X Receptors in Lipid Accumulation in Adipocytes

Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats

456 Efficacy and safety of iptacopan in patients with primary IgA nephropathy: interim analysis results of the Phase 3 APPLAUSE-IgAN study

Safety and Efficacy of Iptacopan in Patients with IgA Nephropathy with Baseline eGFR 20 to <30 mL/min: Phase 3 APPLAUSE-IgAN Subcohort Results: FR-PO853

Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats

Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy

WCN24-1506 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY

Tesaglitazar, a dual PPARα/γ agonist, ameliorates glucose and lipid intolerance in obese Zucker rats

Depression of Myocardial Contractility Is Not a Causative Factor for Circulatory Deterioration in Two Experimental Models of Shock in Anesthetized Dogs

Tesaglitazar, a dual PPARalpha/gamma agonist, ameliorates glucose and lipid intolerance in obese Zucker rats

Salutary Effects of Dopexamine, a DA-1 and β-2 Agonist, on Free Radical-Induced Toxicity in Anesthetized Rats

Tesaglitazar, a dual PPARα/γ agonist, ameliorates glucose and lipid intolerance in obese Zucker rats

Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats

Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-meidated control of systemic FFA availability

Sustained Beneficial Metabolic Effects after Cessation of Thiazolidinedione Therapy in Insulin-Resistant Obese Zucker Rats

Thiazolidinediones Alter the Control of Systemic Free Fatty Acid Mobilization and Tissue Specific Utilization in Obese Zucker Rats

Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats

Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats

Effect of pharmacological interventions in the prevention of lipid peroxidation and respiratory depression induced by oxygen free radicals in anesthetized rats

Comparative evaluation of the acute effects of oxygen free radicals on myocardial contractility in anesthetized dogs with those occurring in the early stages of splanchnic artery occlusion and hemorrhagic shock

Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats

Efficacy and Mechanisms of Dopexamine in the Prevention of Ischemia-Reperfusion Induced Organ Damage: Role of Oxygen Free Radicals

Evaluation of the effects of felodipine, verapamil and hydralazine on the survival rate of rats subjected to lethal effects of oxygen free radicals

Studies on the eleterious effects of free radicals on myocardial contractility and hemodynamics in dogs: Protection by felodipine, a dihydropyridine calcium antagonist

Suchergebnisse filtern